Evidence Found of Causal Link for Multisite Chronic Pain and MS, RA

WEDNESDAY, Feb. 22, 2023 (HealthDay News) -- Multisite chronic pain is causally associated with a higher risk for multiple sclerosis (MS) and rheumatoid arthritis (RA), but not with other autoimmune diseases (AIDs), according to a study published online Feb. 9 in Frontiers in Immunology.
Yidan Tang, from Sichuan University in Chengdu, China, and colleagues used a two-sample Mendelian randomization (MR) method to determine the causal relationship between chronic pain and AIDs, namely amyotrophic lateral sclerosis (ALS), celiac disease (CeD), inflammatory bowel disease (IBD), MS, RA, systemic lupus erythematosus (SLE), type 1 diabetes (T1D), and psoriasis using genome-wide association study summary statistics.
The researchers identified associations between multisite chronic pain and a higher risk for MS and RA (odds ratios, 1.59 and 1.72, respectively) with utilization of an MR analysis. No significant effect was seen for multisite chronic pain on ALS, CeD, IBD, SLE, T1D, or psoriasis. Positive causal effects of multisite chronic pain on body mass index (BMI) were identified, as were causal effects of BMI on MS and RA. Genetically predicted chronic widespread pain was not causally connected to the risk for most types of AIDs.
"Our results demonstrated genetic evidence of a potential causal relationship between multisite chronic pain and MS or RA in the European population, which may partially mediate through BMI," the authors write.
Related Posts
Remodeling Your Home for Wheelchair Access
THURSDAY, March 30, 2023 (HealthDay News) -- Millions of Americans get around...
Una terapia ‘pulsada’ para los nervios podría ayudar a aliviar la ciática
MIÉRCOLES, 29 de marzo de 2023 (HealthDay News) -- Las personas que sufren de...
Preexisting Cardiovascular Conditions Tied to Severe COVID-19 in Children
THURSDAY, May 19, 2022 (HealthDay News) -- Some previous or preexisting...
Sen. John Fetterman Enters Hospital for Treatment of Clinical Depression
FRIDAY, Feb. 17, 2023 (HealthDay News) – Sen. John Fetterman is being treated...
